The Outcomes of Core Needle Biopsies in Palpable Breast Masses using Ultrasound-guided versus Palpation-guided
Core Needle Biopsies in Palpable Breast Masses
Keywords:
breast mass/breast cancer, tissue biopsy, core needle biopsy, ultrasound-guidedAbstract
Female breast cancer has now surpassed lung cancer as the leading cause of global cancer incidence and the most commonly diagnosed cancer in all ages and both sexes, the same as the incidence in Thailand. This prospective randomized controlled study was conducted to verify whether ultrasound-guided core biopsies were more accurate than palpation-guided biopsies in palpable breast masses patients that was BIRADS* 3-5, confirmed by ultrasound and/or mammography. This study was a clinical trial by studying data from April 2021 to April 2022. Forty patients were randomized into two groups: 20 patients were palpation-guided core needle biopsy group and 20 patients were ultrasound-guided core needle biopsy group. The accuracy based on core needle biopsy results of the ultrasound-guided core needle biopsy group and the palpation-guided core needle biopsy group were 95% and 85% respectively. The PPV was 100% and 100%, NPV was 85.7% and 100%, and FN was 7.1% and 0%, respectively. The results from this study suggest and encourage that ultrasound-guided core needle biopsy should be performed by surgeons and general surgery residents allowing for a safe, fast, feasible, effective, bedside, low-cost procedure and good accuracy and significantly more accurate than biopsy using palpation-guided.
References
Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 2021;127(16):3029-30.
World Health Organization. Global health estimates: Leading causes of death. Cause-specific mortality, 2000–2019 [Internet]. [updated 2021 Mar, cited 202 Sep 9]. Available from: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019;144(8):1941-53.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209-49.
Bevers TB, Niell BL, Baker JL, Bennett DL, Bonaccio E, Camp MS, et al. NCCN Guidelines® Insights: Breast cancer screening and diagnosis, Version 1.2023. J Natl Compr Canc Netw 2023;21(9):900-9.
Tomkovich KR. Interventional radiology in the diagnosis and treatment of diseases of the breast: A historical review and future perspective based on currently available techniques. AJR Am J Roentgenol 2014;203(4):725-33.
Dahabreh IJ, Wieland LS, Adam GP, Halladay C, Lau J, Trikalinos TA. Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Sep. Report No.: 14-EHC040-EF. PMID: 25275206.
D’Orsi C.J, Sickles EA, Mendelson EB, Morris EA. ACR BI-RADS Breast Imaging and Reporting Data System : Breast Imaging Atlas. 5th ed. Reston, Verginia State, USA: American College of Radiology; 2013.
Schueller G, Jaromi S, Ponhold L, Fuchsjaeger M, Memarsadeghi M, Rudas M, et al. US-guided 14-gauge core-needle breast biopsy: Results of a validation study in 1,352 cases. Radiology 2008;248(2):406-13.
Schueller G, Schueller-Weidekamm C, Helbich TH. Accuracy of ultrasound-guided, large-core needle breast biopsy. Eur Radiol 2008;18(9):1761-73.
Perrot N, Jalaguier-Coudray A, Frey I, Thomassin-Naggara I, Chopier J. US-guided core needle biopsy: False-negatives. How to reduce them? Eur J Radiol 2013;82(3):424-6.
Hari S, Kumari S, Srivastava A, Thulkar S, Mathur S, Veedu PT. Image guided versus palpation guided core needle biopsy of palpable breast masses: A prospective study. Indian J Med Res 2016;143(5):597-604.
Bick U, Trimboli RM, Athanasiou A, Balleyguier C, Baltzer PAT, Bernathova M, et al. Image-guided breast biopsy and localization: Recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging 2020;11(1):12. doi: 10.1186/s13244-019-0803-x
Sun T, Zhang H, Gao W, Yang Q. The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer. Medicine (Baltimore) 2021;100(14):e25400. doi: 10.1097/MD.0000000000025400
Arnedos M, Nerurkar A, Osin P, A'Hern R, Smith IE, Dowsett M. Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol 2009;20(12):1948-52.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Buddhchinaraj Phisanulok Hospital
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
